Viewpoint


(EU) No 540/2011) but are not successfully re-registered


2. The active substance(s) contained in the product are withdrawn from/not renewed on the list of approved active substances included in Regulation (EU) No 540/2011


3. Significant safety or efficacy concerns with the product or a specific use


4. A requirement for the submission of data to continue with the authorisation of the product or a specific use is not met


5. Data submitted in support of an application does not support the continuing authorisation of the product or a specific use


6. A product or a specific use is commercially withdrawn


7. For products not authorised/permitted to uniform principles at the final commission deadline for re-registration of all active substances in the product


8. False or misleading information was


submitted to support an authorisation/permit


Manufacturers have detailed knowledge of their products and liaise extensively with CRD regarding re-approvals. To the public, it may be perceived that the chemical company has simply not bothered to resubmit a renewal application, (this is only the case when the product has no commercial case for resubmission). It is almost always a health risk, excess


residue levels in water, or examples of negative impact on sensitive bio-organisms that, with close liaison with the Chemicals Regulation Division (CRD), indicates to the authorisation holder that there is no or a very little chance that going through the financial and time investment of resubmission would result in a product re- approval being granted. In extreme cases, such as the withdrawal of chlorpyrifos, it is likely the manufacturer acted on known risk, or as a result of an identified problem, took an ethical and/or


responsible decision after close liaison with CRD.


With rapid changes to active ingredients, it is important that end users understand exactly which products have revocations against them, the sell up and end user period of approved application for them. The Health and Safety Executive is the government department responsible for issuing information on product withdrawals. To avoid stock issues with any withdrawn products, ensure you refer to the HSE authorised products page: https://secure.pesticides.gov.uk/pestreg Alternatively, use a BASIS qualified amenity


advisor to ascertain dates, or ask questions you may have about chemical revocation.


Changes occurring


The amenity market faces significant challenges in the immediate future. A wide number of active ingredients are under scrutiny or have impending withdrawals. This will change the way we have to prepare and strategise for problems going forward.


PC JUNE/JULY 2017 I 13


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156